Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

621 Real World Study

NCT: NCT05646004 · COMPLETED

NCT IDNCT05646004
StatusCOMPLETED
Start Date2023-01-09
Completion2023-11-27
SponsorCarl Zeiss Meditec AG (INDUSTRY)
First posted
Last updated

Brief Summary

This study is evaluating the clinical safety and effectiveness of 621, after cataract surgery.

Frequently Asked Questions

What is 621 Real World Study?

621 Real World Study is a clinical trial registered under NCT05646004. Current status: COMPLETED.

What is the status of NCT05646004?

The current status of NCT05646004 (621 Real World Study) is: COMPLETED.

When did 621 Real World Study start?

621 Real World Study started on 2023-01-09.

Related Devices

K161194PLEX Elite 9000 SS-OCTCarl Zeiss Meditec, Inc. K161607VISULUXCarl Zeiss Meditec, AG K162568INTRABEAM 600Carl Zeiss Meditec, AG K162684SL 220Carl Zeiss Meditec, AG K162991YELLOW 560 Fluorescence ModuleCarl Zeiss Meditec, AG

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑